Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Balaji Speciality Chemicals manufactures niche chemicals such as ethylene diamine, piperazine anhydrous, diethylenetriamine, aminoethyl ethanolamine and aminoethyl piperazine, using the monoethanol amine process.

Balaji Amines arm files DRHP with Sebi for IPO

Balaji Amines’ consolidated net profit rose 36% to Rs 122.96 crore on a 48.7% increase in revenue from operations to Rs 670.17 crore in Q1 FY23 over Q1 FY22.

Balaji Amines Q1 PAT 36% YoY to Rs 123 cr

Balaji Amines update on proposed IPO of subsidiary - Balaji Speciality Chemicals

Hindustan Foods Ltd, Repco Home Finance Ltd, Balaji Amines Ltd and Rain Industries Ltd are among the other gainers in the BSE’s ‘A’ group today, 22 July 2022.

Gujarat State Fertilizers & Chemicals Ltd leads gainers in ‘A’ group

Shareholders of Wires and Fabriks, Golkunda Diamonds And Jewellery, Tinna Rubber & Infrastructure, Panasonic CarbonIndia, Polycab, Nelco, Amrit Corporation, Balaji Amines, and Supreme should be aware that these companies have set June 22, 2022 as the record date for the purpose of dividends, and thu…

9 stocks that shall turn ex-dividend tomorrow

Balaji Amines rallied 4.37% to Rs 3394.75 after the company said that board of its material subsidiary, Balaji Speciality Chemicals (BSCL), approved raising funds through an initial public offering (IPO).

Balaji Amines jumps as subsidiary to launch IPO

Buzzing stocks: Reliance Industries, Religare, Vedanta, REC, GR Infraprojects, Balaji Amines, Delta Corp, Knowledge Marine and Mishtann Foods

Stocks that will see action today June 02

"88% jump in revenues was led by volume and value growth in specific products like DMF or Dimethylformamide", says D Ram Reddy, MD, Balaji Amines. Expects revenue to be around Rs 4,000 crore by FY25 or FY26. 
Read: https://bit.ly/3MckaCR

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/

Balaji Amines Expects Revenue Growth Of Over 70% By FY25-26

Balaji Amines reports 66% jump in sales but profit rises a meagre 3%.
MD D Ram Reddy shares fineprint of quarter gone by and demand scenario for the sector. #Q4WithBQ #BQLive

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/

Q4 Results: Balaji Amines' MD On Earnings & FY23 Projections

Balaji Amine’s project execution is worth noticing, due to which earnings potential has significantly increased over the years

Balaji Amines: An eagle eye for import substitution opportunities

Balaji Amines Consolidated March 2022 Net Sales at Rs 779.04 crore, up 88.16% Y-o-Y

Balaji Amines Limited is a company, which is engaged in the manufacturing of Aliphatic Amines, their derivatives and specialty chemicals. The Company is running a five star hotel, Balaji Sarovar Premiere.

Balaji Amines Ltd

Balaji Amines Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Balaji Amines arm files DRHP with Sebi for IPO

Balaji Amines Q1 PAT 36% YoY to Rs 123 cr

Balaji Amines update on proposed IPO of subsidiary - Balaji Speciality Chemicals

Gujarat State Fertilizers & Chemicals Ltd leads gainers in ‘A’ group

9 stocks that shall turn ex-dividend tomorrow

Balaji Amines jumps as subsidiary to launch IPO

Stocks that will see action today June 02

News Video

Balaji Amines Expects Revenue Growth Of Over 70% By FY25-26

News Video

Q4 Results: Balaji Amines' MD On Earnings & FY23 Projections

Balaji Amines: An eagle eye for import substitution opportunities

Balaji Amines Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Balaji Amines arm files DRHP with Sebi for IPO

Balaji Amines Q1 PAT 36% YoY to Rs 123 cr

Balaji Amines update on proposed IPO of subsidiary - Balaji Speciality Chemicals

Gujarat State Fertilizers & Chemicals Ltd leads gainers in ‘A’ group

9 stocks that shall turn ex-dividend tomorrow

Balaji Amines jumps as subsidiary to launch IPO

Stocks that will see action today June 02

News Video

Balaji Amines Expects Revenue Growth Of Over 70% By FY25-26

News Video

Q4 Results: Balaji Amines' MD On Earnings & FY23 Projections

Balaji Amines: An eagle eye for import substitution opportunities

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock